S Elad

66PUBLICATIONS

478CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersAnimal systematics and taxonomyMolecular targetsTransplantation immunology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (66)

Sort by Publication Date:

|Jun 30, 2026

A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancer.

|Jun 23, 2026

Addressing Biases in Analysis of Time of Infusion: NCI/SWOG Trial S1404 Among Participants With High-Risk Resectable Melanoma Who Received Adjuvant Anti-PD-1 Therapy.

|Jun 08, 2026

Cancer chemo-immunotherapy: time will tell.

|Apr 18, 2026

Atezolizumab for Alveolar Soft Part Sarcoma: A Clinical Trial Update.

|Apr 17, 2026

A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: vaginal cancer sub cohort results.

|Apr 06, 2026

Antigen-specific T-cell responses to SARS-CoV-2 vaccination after hematopoietic cell transplant or CAR T-cell therapy.

Sigrun Einarsdottir, Teng Fei, Katina H Singh

Pageof 11

Frequent Collaborators

Megan Othus

Razelle Kurzrock

Abdul Rafeh Naqash

Young Kwang Chae

Sandip Pravin Patel

Alice P Chen

Douglas B Johnson

Lawrence Rubinstein

Naoko Takebe

Helen X Chen

Frequent Collaborators

Megan Othus

Razelle Kurzrock

Abdul Rafeh Naqash

Young Kwang Chae